An innovative approach of cryopreserving red blood cells using vitrification in conjunction with bio-printing technologies has been described in a new collaborative study published this week in Advanced Materials. The study, led by Dr. Utkan Demirci, is a collaboration involving scientists from Stanford University School of Medicine, Harvard Medical School, Case Western Reserve University, Worcester Polytechnic Institute, and Akron Biotechnology.
Students who took part in the largest-ever Summer Internship Program class at the newly merged SUNY College of Nanoscale Science and Engineering (CNSE) / SUNY Institute of Technology (SUNYIT) shared their advanced, nanotechnology-related research at a public poster presentation on Friday, August 8.
UC San Francisco researchers have identified cells’ unique features within the developing human brain, using the latest technologies for analyzing gene activity in individual cells, and have demonstrated that large-scale cell surveys can be done much more efficiently and cheaply than was previously thought possible.
Muscle physiologist Edward Debold at the University of Massachusetts Amherst’s School of Public Health and Health Sciences recently received a three-year, $198,000 grant from the American Heart Association to support studies to uncover the molecular mechanisms of skeletal muscle fatigue.
In every cell in your body, tiny protein motors are toiling away to keep you going. Moving muscles, dividing cells, twisting DNA – they are the workhorses of biology. But there is still uncertainty about how they function. To help biologists in the quest to know more, a team of Stanford bioengineers has designed a suite of protein motors that can be controlled remotely by light.
Marija Drndiæ, a professor in the Department of Physics & Astronomy in the University of Pennsylvania's School of Arts & Sciences has been awarded a two-year, $880,000 grant for a project aimed at reducing the cost and time of genome sequencing. The grant was made by the National Human Genome Research Institute of the National Institutes of Health.
Researchers from McGill University and the Génome Québec Innovation Centre have achieved a technical breakthrough that should result in speedier diagnosis of cancer and various pre-natal conditions.
This was determined using Small-Angle X-ray Scattering (SAXS) at BESSY II. A thorough examination with an electron microscope (TEM) confirmed their result. "The research on this phenomenon is now proceeding because we are convinced that such nanoclusters lend themselves as catalysts, whether in fuel cells, in photocatalytic water splitting, or for other important reactions in chemical engineering", explains Dr. Armin Hoell of HZB. The results have just appeared in two peer reviewed international academic journals.
EPFL scientists reveal for the first time the 3D structure of a crucial neuroreceptor. The achievement has great implications for understanding the basic mechanism of electrical signal transmission between neurons and might help to design novel medicines to treat various neurological diseases.
A fast and cost-effective genetic test to determine the correct dosage of blood thinning drugs for the treatment of stroke, heart problems and deep vein thrombosis has been developed by researchers at the Institute of Bioengineering and Nanotechnology (IBN). Using gold nanoprobes, this new technology offers personalized healthcare based on the genetic profile of the patients.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.